SDIC Power and others have invested in the establishment of a new energy development company. The enterprise search APP shows that recently, Ganzi Yalongjiang Energy Development Co., Ltd. was established with Zhang Peng as its legal representative and a registered capital of 500 million yuan. Its business scope includes: solar power generation technical services; Research and development of emerging energy technologies; Technical services for wind power generation; Energy storage technology services, etc. Enterprise equity penetration shows that the company is jointly owned by Yalong River Basin Hydropower Development Co., Ltd. and Ganzi Energy Development Group Co., Ltd., a subsidiary of SDIC Power.On the 11th, iron ore fell by 1.64%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract iron ore was closed at 2501, up or down by -1.64%, with a turnover of 165,400 lots. The position data showed that the top 20 seats were clear, and the difference position was 14,975 lots. Iron ore futures contracts totaled 429,100 lots, a decrease of 195,200 lots from the previous day. The first 20 seats in the contract held 462,200 lots, a decrease of 6,055 lots from the previous day. There were 481,400 short positions in the top 20 seats of the contract, an increase of 7,172 lots over the previous day. (Sina Futures)Guotai Junan expects Hong Kong stocks to fluctuate upward in an N-shaped pattern next year to explore domestic demand and improve investment opportunities. Chen Ximiao, chief analyst of Guotai Junan's overseas strategy, said that looking forward to 2025, the disturbance factors in the Hong Kong stock market from the external environment will continue, and the pace of interest rate cuts by the Federal Reserve under overseas inflation, policy restrictions in areas such as strong US dollar and tariffs, and game friction among big countries will continue. However, the domestic policy thinking is clear, economic expectations are expected to stabilize under the financial impetus, and the profitability of molecular enterprises will improve, and the industrial chain will be able to cope with it. She said that in 2025, the sensitivity of the Hong Kong stock market to external shocks is expected to decline, and more attention should be paid to returning to its own logic. For the trend of Hong Kong stocks in 2025, it is expected to be dominated by the upward pattern of N-shaped shocks, and there are many opportunities for flexibility during the stage. In 2025, we should still actively look for the structure, and focus on the barbell strategy to shift the weight of the two ends. We need to pay more attention to the configuration rhythm and pay attention to the repair opportunities of some domestic products.
Sichuan Bank successfully issued 5.4 billion tier-2 capital bonds for the first time, with a subscription multiple of 6.6 times. Sichuan Bank completed its first capital bond issuance on December 10th. According to the information released by China Foreign Exchange Trading Center, the scale of Tier 2 capital bonds issued by Sichuan Bank this time is 5.4 billion yuan, and the subscription multiple is as high as 6.6 times, while that of coupon rate is 2.20%, with a term of 5+5 years. This bond attracted more than 100 institutional investors including banks, brokers, funds, trusts and wealth management subsidiaries to participate in the subscription, with a cumulative investment of more than 35 billion yuan.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.With the intensive IPO process of domestic semiconductor companies, we can seize new opportunities in the semiconductor chip industry through the semiconductor ETF(512480). On December 11th, the semiconductor ETF(512480) closed up 0.20% with a turnover of 1.29 billion yuan. The constituent stocks are mixed. In terms of rising, the Cambrian led the rise, and Weir shares followed. In terms of decline, Zhongwei Company led the decline, and Haiguang Information followed suit. In the news, in the fourth quarter of 2024, the IPO acceptance review in science and technology innovation board has been accelerated, with 12 companies updating their review status, mostly in the semiconductor industry. According to industry insiders, from the current audit dynamics, materials, parts and components in the upstream of the industry, as well as AI chips in the design process, may be more popular in the future. Guojin Securities pointed out that semiconductor self-control is the general trend, and it is optimistic about semiconductor equipment parts, materials and domestic computing power industry chain. CITIC Securities said that it is expected that the overall localization pace of the domestic semiconductor industry will be further accelerated, and the manufacturing sector is also expected to benefit. Investors can take advantage of the semiconductor ETF(512480) to grasp the new opportunities in the semiconductor chip industry.
Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.Governor of Belgorod, Russia: Ukrainian troops fired more than 30 shells in Belgorod within 24 hours, causing no casualties or property losses.Regulatory measures were taken to adjust the net worth management of wealth management subsidiaries and standardize the smooth valuation in violation of regulations. The reporter was informed that some wealth management subsidiaries should not reduce the fluctuation of product net worth through illegal means, such as closing price adjustment, smooth valuation or self-built valuation model. This circular requires financial subsidiaries to use the current valuation data provided by China Bond, China Securities and foreign exchange trading centers, and at the same time, the asset management plan needs to implement penetrating management to ensure that the asset management products are consistent with the company's valuation of the same type of assets in terms of valuation principles, policies, technologies and methods. An industry insider told reporters that this move reflects the clear intention of supervision and requires wealth managers to take the road of net worth. (CBN)
Strategy guide
12-14
Strategy guide